Emerging infectious diseases in Alaska and the Arctic: a review and a strategy for the 21st century.
Emergence of new, previously unknown, and drug-resistant infectious diseases pose a major threat to global health. The emergence of infectious diseases in Alaska and the Arctic parallels the resurgence of infectious diseases worldwide. The Centers for Disease Control and Prevention has developed a strategy to revitalize the capacity to protect the public from emerging infectious diseases by improving four major public health activities: surveillance and response, applied research, infrastructure and training, and prevention and control. The plan targets high-priority emerging infectious disease problems and particular groups of people at increased risk. These target areas encompass a number of diseases of special concern in Alaska, such as drug-resistant Streptococcus pneumoniae infections, foodborne botulism, alveolar hydatid disease, viral hepatitis, Helicobacter pylori infections, Haemophilus influenzae type b bacteremia and meningitis, and infections of immunocompromised persons, pregnant women and newborns, and tourists. To address these and other emerging infectious disease issues, including the threat of bioterrorism in Alaska and the Arctic, future issues of Alaska Medicine will include updates on specific emerging infectious diseases for health care providers, clinical laboratory workers, and community public health professionals who form the front lines for recognizing, treating, and preventing emerging infectious diseases.
Butler
J C
JC
Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA. JCB3@CDC.GOV
Parkinson
A J
AJ
Funk
E
E
Beller
M
M
Hayes
G
G
Hughes
J M
JM
D000413:Alaska / Q000453:epidemiology; D001110:Arctic Regions / Q000453:epidemiology; D003140:Communicable Disease Control / Q000458:organization & administration*; D003141:Communicable Diseases / Q000453:epidemiology*; D004197:Disease Reservoirs; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D017589:Immunization Programs; D016867:Immunocompromised Host; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology